11920175

Source:http://linkedlifedata.com/resource/pubmed/id/11920175

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0022417, umls-concept:C0030705, umls-concept:C0033325, umls-concept:C0033522, umls-concept:C0334634, umls-concept:C0936012, umls-concept:C1831743
pubmed:issue	2
pubmed:dateCreated	2002-3-28
pubmed:abstractText	The purpose of this analysis was to investigate if early sequential high-dose therapy with autologous stem cell transplantation (ASCT) can improve the poor prognosis of patients with disseminated mantle cell lymphoma (MCL).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/100965523
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Carmustine, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Dexamethasone, http://linkedlifedata.com/resource/pubmed/chemical/Doxorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Melphalan, http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status	MEDLINE
pubmed:issn	1466-4860
pubmed:author	pubmed-author:DregerPP, pubmed-author:GlassBB, pubmed-author:HaasRR, pubmed-author:KnebaMM, pubmed-author:KrögerNN, pubmed-author:KuseRR, pubmed-author:MartinSS, pubmed-author:ParwareschRR, pubmed-author:SchmitzNN, pubmed-author:SonnenRR
pubmed:issnType	Print
pubmed:volume	1
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	87-94
pubmed:dateRevised	2006-11-15
pubmed:meshHeading	pubmed-meshheading:11920175-Adult, pubmed-meshheading:11920175-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11920175-Bone Marrow, pubmed-meshheading:11920175-Carmustine, pubmed-meshheading:11920175-Cyclophosphamide, pubmed-meshheading:11920175-Cytarabine, pubmed-meshheading:11920175-Dexamethasone, pubmed-meshheading:11920175-Disease-Free Survival, pubmed-meshheading:11920175-Doxorubicin, pubmed-meshheading:11920175-Etoposide, pubmed-meshheading:11920175-Female, pubmed-meshheading:11920175-Hematopoietic Stem Cell Mobilization, pubmed-meshheading:11920175-Hematopoietic Stem Cell Transplantation, pubmed-meshheading:11920175-Humans, pubmed-meshheading:11920175-Immunophenotyping, pubmed-meshheading:11920175-Lymphoma, Mantle-Cell, pubmed-meshheading:11920175-Male, pubmed-meshheading:11920175-Melphalan, pubmed-meshheading:11920175-Middle Aged, pubmed-meshheading:11920175-Neoplasm Staging, pubmed-meshheading:11920175-Prednisolone, pubmed-meshheading:11920175-Prednisone, pubmed-meshheading:11920175-Prognosis, pubmed-meshheading:11920175-Survival Rate, pubmed-meshheading:11920175-Time Factors, pubmed-meshheading:11920175-Transplantation, Autologous, pubmed-meshheading:11920175-Treatment Outcome, pubmed-meshheading:11920175-Vincristine, pubmed-meshheading:11920175-Whole-Body Irradiation
pubmed:year	2000
pubmed:articleTitle	The impact of autologous stem cell transplantation on the prognosis of mantle cell lymphoma: a joint analysis of two prospective studies with 46 patients.
pubmed:affiliation	Second Department of Medicine, University of Kiel, Germany.
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Controlled Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study